Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

6.37
Delayed Data
As of May 29
 +0.24 / +3.92%
Today’s Change
6.03
Today|||52-Week Range
12.88
-32.16%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close6.13
Today’s open6.13
Day’s range6.05 - 6.47
Volume1,089,038
Average volume (3 months)1,240,494
Market cap$266.9M
Dividend yield--
Data as of 4:14pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-34.41%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll AG+0.43+3.80%
GALEGalena Biopharma Inc-0.06-3.68%
VTAEVitae Pharmaceutical...-0.17-1.37%
ASMBAssembly Biosciences...+0.76+4.78%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers